APA (7th ed.) Citation

Cai, J., Wei, J., Li, S., Suber, T., & Zhao, J. AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin. Wiley.

Chicago Style (17th ed.) Citation

Cai, Junting, Jianxin Wei, Shuang Li, Tomeka Suber, and Jing Zhao. AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability Through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin. Wiley.

MLA (9th ed.) Citation

Cai, Junting, et al. AM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability Through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin. Wiley.